Assoc. Prof. Dr. Valeriy Bacherikov | Spectroscopy | Excellence in Research

Assoc. Prof. Dr. Valeriy Bacherikov | Spectroscopy | Excellence in Research

Assoc. Prof. Dr. Valeriy Bacherikov | A. V. Bogatsky Physico-Chemical Institute NAS of Ukraine

Valeriy Anatoliyovych Bacherikov is a distinguished scientist in organic and medicinal chemistry, specializing in stereochemistry, supramolecular chemistry, and pharmaceutical applications. His research focuses on the design, synthesis, and study of biologically active compounds, including antiviral agents targeting coronavirus proteases. He has contributed to the development and clinical evaluation of antiviral drugs such as Amizon, demonstrating their efficacy in viral infections and reducing complications. Bacherikov also explores the use of medicinal herbs in pharmaceutical and cosmetic formulations, highlighting modern trends in phytopharmaceutical research. He has investigated alternative strategies to combat antibiotic resistance, including chromium-based solutions and innovative therapeutic approaches. His publications in national and international journals and conference proceedings reflect broad scientific influence and a commitment to advancing chemical and biomedical knowledge. He actively organizes scientific conferences, particularly in pharmacology, cosmetology, and aromology, and serves as a peer reviewer for high-impact journals, supporting rigorous scientific standards. Bacherikov mentors students and junior researchers in chemistry, biochemistry, and pharmaceutical sciences, cultivating the next generation of scientists. His work bridges fundamental chemical research and practical biomedical applications, demonstrating the translational value of his studies. Recognized for integrating organic chemistry with pharmacological insights, he continues to advance antiviral drug design, supramolecular chemistry, and phytopharmaceutical development. Through teaching, research supervision, and active participation in scientific communities, he influences both academic and applied research landscapes. His ongoing studies promise further advancements in antiviral agents, novel therapeutics, and interdisciplinary approaches in pharmaceutical sciences.

Profile: Orcid

Featured Publications

Zlatov, Y., Bacherikov, V., Teslyuk, O., Zheltvay, I., Ognichenko, L., & Derkach, L. (2026). Study of luminescence properties of lanthanide complexes of dehydroacetic acid derivatives. Journal of Luminescence. Advance online publication.

Bacherikov, V. (2022). Total synthesis, mechanism of action and antitumor efficacy of camptothecin and some of its analogues. Anti-Cancer Agents in Medicinal Chemistry, 22(5), 501–517.

Bacherikov, V. A., Chittiboyina, A. G., & Avery, M. A. (2017). Design, synthesis, and biological evaluation of peptidomimetic N-substituted Cbz-4-Hyp-Hpa-amides as novel inhibitors of Plasmodium falciparum. Chemistry & Biodiversity, 14(7), e1700037.

Bacherikov, V. V., & Bacherikov, V. A. (2015). Dr. Samokhotskiy's method of healing inflammation by the analysis and regulation of blood electrolyte balance. Journal of Experimental Therapeutics & Oncology.

Bacherikov, V. (2015). Strategy and preparation of some building blocks for synthesis of branched oligosaccharides. Odessa National University Herald. Series: Chemistry, 1(53), 445–453.

Cüneyt Uğur | Medicine | Molecular Physics Achievement Award

Assoc Prof Dr. Cüneyt Uğur | Medicine | Molecular Physics Achievement Award

University of Health Sciences | Turkey

Author Profile:

 Early Academic Pursuits:

Cüneyt Uğur embarked on his academic journey with a foundation in management and organization at Anadolu University's Open Education Faculty. His dedication to expanding his academic horizons led him to pursue a degree in Medicine at Istanbul University, where he delved into the intricate world of medical sciences.

Professional Endeavors:

Dr. Cüneyt Uğur's professional journey began with his role as a Doctoral Teaching Member at the Health Sciences University in Konya. This marked the initiation of his dedicated service to the medical field, where he contributed significantly to both education and research.

Contributions and Research Focus:

As a Doctoral Teaching Member, Dr. Uğur took on the responsibility of guiding and supervising research endeavors. His notable contributions include overseeing theses on diverse topics, such as the evaluation of serum zinc and vitamin D levels in children with acute gastroenteritis related to rotavirus and assessing cases of multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19. Additionally, he actively participated in research projects, particularly those focusing on pediatric diseases like acute appendicitis.

Accolades and Recognition:

Dr. Cüneyt Uğur's commitment to research and excellence has earned him recognition in various projects and research groups. His involvement in the Turkish MIS-C Study Group showcases his acknowledgment as a leader in evaluating cases of multisystemic inflammatory syndrome in children associated with COVID-19. This recognition underscores his expertise and dedication to advancing the understanding of pediatric diseases.

Impact and Influence:

As a Doctoral Teaching Member, Dr. Uğur's impact extends beyond the classroom. His involvement in projects related to pediatric health and diseases demonstrates a commitment to improving the medical field's understanding and treatment of these conditions. Through his leadership and active participation in research groups, he contributes to the broader scientific community's knowledge.

Legacy and Future Contributions:

Dr. Cüneyt Uğur's legacy lies in his significant contributions to the fields of pediatrics and medical research. His guidance and supervision of numerous theses and research projects have undoubtedly influenced the next generation of medical professionals. Looking ahead, his commitment to ongoing research and academic excellence positions him to continue shaping the future of pediatric medicine, leaving a lasting impact on the field.

Notable Publication:

Are decreased cocaine- and amphetamine regulated transcript and Agouti- related peptide levels associated Eating behavior in medication-free children with attention deficit and hyperactivity disorder?  8 February 2024

Evaluation of newborn hearing screening results of infants with phenylketonuria February 2024